Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase ActivityJack D. Scott, Michael W. Miller, Marco A. S. Baptista et al.|Journal of Medicinal Chemistry|2017Cited by 147
Hydroxyl-Group-Dominated Graphite Dots Reshape Laser Desorption/Ionization Mass Spectrometry for Small Biomolecular Analysis and ImagingRui Shi, Jian Liu, Shuit‐Tong Lee et al.|ACS Nano|2017Cited by 112
Turn-up Luminescent Sensing of Ultraviolet Radiation by Lanthanide Metal–Organic FrameworksSida Zhang, Shuao Wang, Feng Huang et al.|Inorganic Chemistry|2022Cited by 18